← Browse by Condition
Medical Condition

ebv

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT01011712
Recruiting

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise

Enrollment
600 pts
Location
United States
Sponsor
National Institute of Allergy ...
View Trial →
NCT06908096 Phase 1
Recruiting

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

Enrollment
750 pts
Location
United States
Sponsor
National Institute of Allergy ...
View Trial →